NCT05226949View on ClinicalTrials.gov

Host RNA Expression Profiles and Protein Biomarkers in Neonatal Herpes Simplex Virus Infection

CompletedOBSERVATIONAL
Enrollment

159

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

February 28, 2022

Study Completion Date

April 30, 2022

Conditions
Neonatal Herpes Simplex InfectionNeonatal HSV InfectionNeonatal InfectionNewborn; InfectionHerpes Simplex Virus InfectionNeonatal SepsisNeonatal DeathViral Infection
Trial Locations (2)

2100

Department of Paediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen

2300

Department of Congenital Disorders, Statens Serum Institut, Copenhagen

All Listed Sponsors
collaborator

Statens Serum Institut

OTHER

lead

Rigshospitalet, Denmark

OTHER

NCT05226949 - Host RNA Expression Profiles and Protein Biomarkers in Neonatal Herpes Simplex Virus Infection | Biotech Hunter | Biotech Hunter